The goal of this project is to develop integrative approaches for the detection of biomarkers from multiscale genomic and imaging data, so that multiple mental illnesses such as schizophrenia (SC), Unipolar (UD) and bipolar (BI) disorder can be better identified. Imaging genetics is an emerging technique, which integrates imaging and genomic approaches to explore the association between genetic variations and brain functions and behaviors. Although it promises a better and more powerful approach for disease diagnosis and prognosis, the field is facing several major challenges: 1) First, most of current imaging genetics studies focus on pair-wise data correlation and integration; other important genetic factors such as epigenomics and genetic interactions (epistasis) have not been incorporated. 2) Second, multiscale imaging genetics data often exhibit specific characteristics such as inter- correlations, but this prior knowledge has not been incorporated into existing integrative models. 3) Finally, there is a high dimensionality problem with the analysis of imaging genetic data the number of sample is always significantly less than that of features. The solution of these problems necessitates a paradigm shift in computational models by considering the specific characteristics of these multiscale and multimodal data. Our multidisciplinary research team consisting of imaging scientist (Dr. Calhoun), statistical geneticist (Dr. Deng), biomedical engineer and bioimaging informatician (Dr. Wang), and psychiatrist (Dr. Pearson) has worked productively and creatively over the past few years in developing a number of data integration methods for fusion of imaging and genomic data. Building on our initial success, we will accomplish the following specific aims: 1) to study the correlation between multiple imaging and genomic data for the detection of epistasis factors or interaction networks; 2) to integrate multiscale imaging and genomic data, especially incorporating epistasis factors, for the identification of biomarkers, from which risk genes can be better detected; 3) to apply the detected biomarkers for the classification of multiple mental illnesses that are currently based on symptoms and are often misdiagnosed; and 4) to develop and disseminate an open source sparse model based data integration toolbox to the broad research community. The project will make significant impact on more accurate classification of clinically cryptic subgroups (e.g., SC, UD, BI) with an innovative and integrative paradigm by taking into account specific features of multiscale imaging genomic data and incorporation of prior knowledge. This will bring transformative changes on the current diagnosis of these mental illnesses (e.g., primarily based on imaging symptoms, which are often inaccurate), promising for personalized and optimal treatments. The developed methodology and tools are also applicable to many other neurological and psychiatric disorders. By the dissemination of the developed software tools to the research community, the project will have a broad and sustained impact.

Public Health Relevance

This project will challenge the current paradigm on mental illness diagnosis, which relies primarily on symptom assessment or single modality imaging. Our integrative approach (e.g., combining imaging with genomic and epigenomic biomarkers) promises a better discrimination of multiple mental illnesses, translating into individualized and optimal disease management and treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH104680-03
Application #
9115715
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Koester, Susan E
Project Start
2014-08-01
Project End
2018-07-31
Budget Start
2016-08-01
Budget End
2017-07-31
Support Year
3
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Tulane University
Department
Biomedical Engineering
Type
Schools of Arts and Sciences
DUNS #
053785812
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Zhu, W; Xu, C; Zhang, J-G et al. (2018) Gene-based GWAS analysis for consecutive studies of GEFOS. Osteoporos Int 29:2645-2658
Pei, Yu-Fang; Hu, Wen-Zhu; Yan, Min-Wei et al. (2018) Joint study of two genome-wide association meta-analyses identified 20p12.1 and 20q13.33 for bone mineral density. Bone 110:378-385
Zille, Pascal; Calhoun, Vince D; Wang, Yu-Ping (2018) Enforcing Co-Expression Within a Brain-Imaging Genomics Regression Framework. IEEE Trans Med Imaging 37:2561-2571
Lin, Xu; Peng, Cheng; Greenbaum, Jonathan et al. (2018) Identifying potentially common genes between dyslipidemia and osteoporosis using novel analytical approaches. Mol Genet Genomics 293:711-723
Alam, Md Ashad; Fukumizu, Kenji; Wang, Yu-Ping (2018) Influence Function and Robust Variant of Kernel Canonical Correlation Analysis. Neurocomputing 304:12-29
Fang, Jian; Xu, Chao; Zille, Pascal et al. (2018) Fast and Accurate Detection of Complex Imaging Genetics Associations Based on Greedy Projected Distance Correlation. IEEE Trans Med Imaging 37:860-870
Zille, Pascal; Calhoun, Vince D; Stephen, Julia M et al. (2018) Fused Estimation of Sparse Connectivity Patterns From Rest fMRI-Application to Comparison of Children and Adult Brains. IEEE Trans Med Imaging 37:2165-2175
Dong, Shan-Shan; Yao, Shi; Chen, Yi-Xiao et al. (2018) Detecting epistasis within chromatin regulatory circuitry reveals CAND2 as a novel susceptibility gene for obesity. Int J Obes (Lond) :
Lv, Wan-Qiang; Zhang, Xue; Fan, Kun et al. (2018) Genetically driven adiposity traits increase the risk of coronary artery disease independent of blood pressure, dyslipidaemia, glycaemic traits. Eur J Hum Genet 26:1547-1553
Zhao, Qi; Shen, Hui; Su, Kuan-Jui et al. (2018) Metabolomic profiles associated with bone mineral density in US Caucasian women. Nutr Metab (Lond) 15:57

Showing the most recent 10 out of 70 publications